Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CD226 encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. Additionally we are shipping CD226 Proteins (18) and CD226 Kits (12) and many more products for this protein.
Showing 10 out of 187 products:
Human Monoclonal CD226 Primary Antibody for Func, FACS - ABIN119797
Kojima, Kanada, Shimizu, Kasama, Shibuya, Nakauchi, Nagasawa, Shibuya: CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. in The Journal of biological chemistry 2003
Show all 3 references for ABIN119797
Human Monoclonal CD226 Primary Antibody for FACS, IP - ABIN119795
Shibuya, Campbell, Hannum, Yssel, Franz-Bacon, McClanahan, Kitamura, Nicholl, Sutherland, Lanier, Phillips: DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. in Immunity 1996
Show all 3 references for ABIN119795
Human Monoclonal CD226 Primary Antibody for FACS - ABIN119800
Shibuya, Lanier, Phillips: Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. in Journal of immunology (Baltimore, Md. : 1950) 1998
Show all 3 references for ABIN119800
Human Monoclonal CD226 Primary Antibody for FACS, Neut - ABIN4899392
Magnani, Alberigo, Bacchetta, Serafini, Andreani, Roncarolo, Gregori: Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells. in European journal of immunology 2011
Human Monoclonal CD226 Primary Antibody for FACS - ABIN1449203
Shibuya, Shirakawa, Kameyama, Honda, Tahara-Hanaoka, Miyamoto, Onodera, Sumida, Nakauchi, Miyoshi, Shibuya: CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. in The Journal of experimental medicine 2003
Data show that CD155 (show PVR Antibodies) protein/CD226 antigen mainly mediates the interaction between NK cells and leukemic cells in acute myeloid leukemia (show BCL11A Antibodies). To investigate the interaction between leukemic cells
absence of either CD155 (show PVR Antibodies) or CD226 in BALB/c mice causes a profound shift in the Natural Killer T-Cells subtype composition in thymus, expanding the frequency and numbers of iNKT1 cells at the expense of iNKT2 cells, as well as iNKT17 cells.
our results suggest a limited role for DNAM-1 in solid allograft rejection. Blocking DNAM-1 is not sufficient to prevent allograft rejection and might be relevant only in combination with additional inhibitors of costimulation.
we propose that expression of DNAM-1 on inflammatory monocytes are evolutionally conserved and act as an adhesion molecule (show NCAM1 Antibodies) on blood inflammatory monocytes.
Data indicate that DNAM-1 (CD226) signaling was required to enhance cytotoxicity.
Regulatory T cells derived (show CD4 Antibodies)from Cd226-deficient mice showed similarly reduced inhibitory activity, eventually resulting in an exacerbated disease course of experimental autoimmune encephalomyelitis.
CD226 limits spontaneous multiple myeloma development in Vk*MYC (show MYC Antibodies) transgenic mice. This is mediated both by NK and CD8 (show CD8A Antibodies)+ T cells through perforin (show PRF1 Antibodies) and IFN-gamma (show IFNG Antibodies) pathways. It also is needed for cyclophosphamide and bortezomib treatment effectiveness.
Findings suggest that TIGIT (show TIGIT Antibodies) is a key checkpoint inhibitor of chronic antiviral and antitumor responses through impairing CD226 function when disrupting its homodimerization.
This synapse defect may explain why DNAM-1-deficient mice cannot clear tumors in vivo.
cooperative signaling through DNAM-1 and Ly49H (show KLRA8 Antibodies) are required for NK cell-mediated host defense against MCMV infection
our results support and explain the mechanism behind the recently reported finding that in EOC, NK-cell recognition and killing of tumor cells was mainly dependent on DNAM-1 signaling while the contribution of the NKG2D (show KLRK1 Antibodies) receptor-ligand pathway was complementary and uncertain.
CD226 rs763361 polymorphism was significantly associated with susceptibility to T1D.
Age and CMV serostatus influence the expression of NKp30 (show NCR3 Antibodies), NKp46 (show NCR1 Antibodies) and DNAM-1 activating receptors on resting and IL-2 (show IL2 Antibodies) activated natural killer cells.
DNAM-1 ligands CD112 (show PVRL2 Antibodies) and CD155 (show PVR Antibodies) as well as the NKG2D (show KLRK1 Antibodies) ligands MICA (show MICA Antibodies) and MICB (show MICB Antibodies) were expressed on the hiPSC lines
The CD226 gene has been identified as novel association with JIA, and a SNP near CD28 (show CD28 Antibodies) as a suggestive association.
Effector and regulatory CD4 (show CD4 Antibodies)+ memory T cells of healthy individuals carrying the predisposing CD226 variant showed, in comparison to carriers of the protective variant, reduced surface expression of CD226 and impaired induction of CD226 after stimulation.
The present study provides evidence that regulation of the PVR/CD155 (show PVR Antibodies) DNAM-1 ligand expression by nitric oxide may represent an additional immune-mediated mechanism and supports the anti-myeloma activity of nitric oxide donors.
our data reveal the existence of a functional program of NK cell maturation marked by DNAM-1 expression.
upregulated CD226 expression on CD8 (show CD8A Antibodies)(+) T cells reflects disease severity and is involved in Systemic sclerosis pathogenesis via the production of various cytokines, including profibrotic IL-13 (show IL13 Antibodies) and endothelial cell injury
This gene encodes a glycoprotein expressed on the surface of NK cells, platelets, monocytes and a subset of T cells. It is a member of the Ig-superfamily containing 2 Ig-like domains of the V-set. The protein mediates cellular adhesion of platelets and megakaryocytic cells to vascular endothelial cells. The protein also plays a role in megakaryocytic cell maturation.
, CD226 molecule
, platelet and T cell activation antigen 1
, platelet and T-cell activation antigen 1
, DNAX accessory molecule 1
, DNAX accessory molecule-1
, T lineage-specific activation antigen 1 antigen
, adhesion glycoprotein